Regulatory Status
Status AC-130 Viper
FDA 510(k) clearance for the AC-130 Viper is pending.
The AC-130 Viper is under development and is not available for commercial distribution in the United States. Product specifications, intended use, labeling, and availability remain subject to regulatory review and may change.
New York Cryogen will update this page when the product’s regulatory status changes. For official
company announcements, join the product-development update list.
Regulatory Status
FDA 510(k) clearance for the AC-130 Viper is pending.
The company will update this website when the product’s regulatory status changes.
Join the Pain Relief Revolution
The AC-130 VIPER is set for distribution in Spring 2024. Healthcare professionals passionate about cutting edge pain relief solutions are encouraged to connect with us.